[43] identified NTRK gene fusions in lung adenocarcinomas, including TPM3‐NTRK1, which confirmed that TPM3‐NTRK1 is a rare but potentially actionable fusion in lung cancer. This evidence concerns the gene TPM3 and lung adenocarcinoma.